{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:46:15Z","timestamp":1780357575498,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1124\/jpet.105.083915","type":"journal-article","created":{"date-parts":[[2005,6,17]],"date-time":"2005-06-17T02:07:56Z","timestamp":1118974076000},"page":"410-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":229,"title":["A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel Transient Receptor Potential Type V1 Receptor Antagonist, Relieves Pathophysiological Pain Associated with Inflammation and Tissue Injury in Rats"],"prefix":"10.1016","volume":"314","author":[{"given":"Prisca","family":"Honore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol T.","family":"Wismer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Mikusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Z.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengmin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Gauvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Gomtsyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"El Kouhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennan","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie R.","family":"Faltynek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.105.083915_bib1","doi-asserted-by":"crossref","unstructured":"Appendino G, Harrison S, De Petrocelli L, Daddario N, Bianchi F, Schiano Moriello A, Trevisani M, Benvenuti F, Geppetti P, and Di Marzo V (2003) Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists. Br J Pharmacol 139: 1417-1424.","DOI":"10.1038\/sj.bjp.0705387"},{"key":"10.1124\/jpet.105.083915_bib2","doi-asserted-by":"crossref","unstructured":"Baron R, Neff L, Louvard D, and Courtoy PJ (1985) Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-k D lysosomal membrane protein at the osteoclast ruffled border. J Cell Biol 101: 2210-2222.","DOI":"10.1083\/jcb.101.6.2210"},{"key":"10.1124\/jpet.105.083915_bib3","doi-asserted-by":"crossref","unstructured":"Bennett GJ and Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: 87-107.","DOI":"10.1016\/0304-3959(88)90209-6"},{"key":"10.1124\/jpet.105.083915_bib4","doi-asserted-by":"crossref","unstructured":"Blair HC, Teitelbaum SL, Ghiselli R, and Gluck S (1989) Osteoclastic bone resorption by a polarized vacuolar proton pump. Science (Wash DC) 245: 855-857.","DOI":"10.1126\/science.2528207"},{"key":"10.1124\/jpet.105.083915_bib5","doi-asserted-by":"crossref","unstructured":"Bove SE, Calcaterra SL, Brooker RM, Huber CM, Guzman RE, Juneau PL, Schrier DJ, and Kilgore KS (2003) Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarth Cartil 11: 821-830.","DOI":"10.1016\/S1063-4584(03)00163-8"},{"key":"10.1124\/jpet.105.083915_bib6","doi-asserted-by":"crossref","unstructured":"Brennan TJ, Vandermeulen EP, and Gebhart GF (1996) Characterization of a rat model of incisional pain. Pain 64: 493-501.","DOI":"10.1016\/0304-3959(95)01441-1"},{"key":"10.1124\/jpet.105.083915_bib7","doi-asserted-by":"crossref","unstructured":"Carlton SM and Coggeshall RE (2001) Peripheral capsaicin receptors increase in the inflamed rat hind paw: a possible mechanism for peripheral sensitization. Neurosci Lett 310: 53-56.","DOI":"10.1016\/S0304-3940(01)02093-6"},{"key":"10.1124\/jpet.105.083915_bib8","doi-asserted-by":"crossref","unstructured":"Caterina MJ and Julius D (2001) The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 24: 487-517.","DOI":"10.1146\/annurev.neuro.24.1.487"},{"key":"10.1124\/jpet.105.083915_bib9","doi-asserted-by":"crossref","unstructured":"Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen ZKR, Koltzenburg M, Basbaum AI, and Julius D (2000) Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science (Wash DC) 288: 306-313.","DOI":"10.1126\/science.288.5464.306"},{"key":"10.1124\/jpet.105.083915_bib10","unstructured":"Cho W and Valtschanoff JG (2004) Vanilloid receptor VR1: positive primary afferents in mouse model of single joint inflammatory osteoarthritis. Program No. 288.15. 2004 Abstract Viewer and Itinerary Planner. San Diego, CA: Society for Neuroscience, online."},{"key":"10.1124\/jpet.105.083915_bib11","doi-asserted-by":"crossref","unstructured":"Cortright DN and Szallasi A (2004) Biochemical pharmacology of the vanilloid receptor TRPV1. An update. Eur J Biochem 271: 1814-1819.","DOI":"10.1111\/j.1432-1033.2004.04082.x"},{"key":"10.1124\/jpet.105.083915_bib12","doi-asserted-by":"crossref","unstructured":"Davis JB, Gray J, Gunthorpe MJ, Hatcher JP, Davey PT, Overend P, Harries MH, Latcham J, Clapham C, Atkinson K, et al. (2000) Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature (Lond) 405: 183-187.","DOI":"10.1038\/35012076"},{"key":"10.1124\/jpet.105.083915_bib13","doi-asserted-by":"crossref","unstructured":"Di Marzo V, Blumberg PM, and Szallasi A (2002) Endovanilloid signaling in pain. Curr Opin Neurobiol 12: 372-379.","DOI":"10.1016\/S0959-4388(02)00340-9"},{"key":"10.1124\/jpet.105.083915_bib14","doi-asserted-by":"crossref","unstructured":"Dinis P, Charrua A, Avelino A, Yaqoob M, Bevan S, Nagy I, and Cruz F (2004) Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis. J Neurosci 24: 11253-11263.","DOI":"10.1523\/JNEUROSCI.2657-04.2004"},{"key":"10.1124\/jpet.105.083915_bib15","doi-asserted-by":"crossref","unstructured":"Doherty EM, Fotsch C, Bo Y, Chakrabarti PP, Chen N, Gavva N, Han N, Kelly MG, Kincaid J, Klionsky L, et al. (2005) Discovery of potent, orally available vanilloid receptor-1 antagonists: structure-activity relationship of N-aryl cinnamides. J Med Chem 48: 71-90.","DOI":"10.1021\/jm049485i"},{"key":"10.1124\/jpet.105.083915_bib16","doi-asserted-by":"crossref","unstructured":"El Kouhen R, Surowy CS, Bianchi BR, Neelands TR, McDonald HA, Niforatos W, Gomtsyan A, Lee C-H, Honore P, Sullivan JP, et al. (2005) A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel and selective TRPV1 receptor antagonist, blocks channel activation by vanilloids, heat and acid. J Pharmacol Exp Ther 314: 400-409.","DOI":"10.1124\/jpet.105.084103"},{"key":"10.1124\/jpet.105.083915_bib17","doi-asserted-by":"crossref","unstructured":"Ferreira J, da Silva GL, and Calixto JB (2004) Contribution of vanilloid receptors to the overt nociception induced by B2 kinin receptor activation in mice. Br J Pharmacol 141: 787-794.","DOI":"10.1038\/sj.bjp.0705546"},{"key":"10.1124\/jpet.105.083915_bib18","doi-asserted-by":"crossref","unstructured":"Fukuoka T, Tokunaga A, Tachibana T, Dai Y, Yamanaka H, and Noguchi K (2002) VR1, but not P2X3, increases in the spared L4 DRG in rats with L5 spinal nerve ligation. Pain 99: 111-120.","DOI":"10.1016\/S0304-3959(02)00067-2"},{"key":"10.1124\/jpet.105.083915_bib19","doi-asserted-by":"crossref","unstructured":"Gavva NR, Tamir R, Qu Y, Klionsky L, Zhang TJ, Immke D, Wang J, Zhu D, Vanderah TW, Porreca F, et al. (2005) AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. J Pharmacol Exp Ther 313: 474-484.","DOI":"10.1124\/jpet.104.079855"},{"key":"10.1124\/jpet.105.083915_bib20","unstructured":"Gillen C, Kurreck J, Christoph T, Grunweller A, Mika J, Schafer MKH, Weihe E, Schiene K, and Erdmann VA (2004) Antinociceptive effect of antisense oligonucleotides and siRNAs against VR1\/TRPV1. Program No. 288.8. 2004 Abstract Viewer and Itinerary Planner. San Diego, CA: Society for Neuroscience, online."},{"key":"10.1124\/jpet.105.083915_bib21","doi-asserted-by":"crossref","unstructured":"Gomtsyan A, Bayburt EK, Schmidt RG, Zheng G-Z, Perner RJ, Didomenico S, Koenig JR, Turner S, Jinkerson T, Drizin I, et al. (2005) Novel transient receptor potential vanilloid 1 (TRPV1) receptor antagonists for the treatment of pain: structure\u2013activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline and cinnoline moieties. J Med Chem 48: 744-752.","DOI":"10.1021\/jm0492958"},{"key":"10.1124\/jpet.105.083915_bib22","doi-asserted-by":"crossref","unstructured":"Gunthorpe MJ, Rami HK, Jerman JC, Smart D, Gill CH, Soffin EM, Hannan SL, Lappin SC, Egerton J, Smith JD, et al. (2004) Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1\/TRPV1) antagonist. Neuropharmacology 46: 133-149.","DOI":"10.1016\/S0028-3908(03)00305-8"},{"key":"10.1124\/jpet.105.083915_bib23","doi-asserted-by":"crossref","unstructured":"Haley JE, Sullivan AF, and Dickenson AH (1990) Evidence for spinal N-methyl-d-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res 518: 218-226.","DOI":"10.1016\/0006-8993(90)90975-H"},{"key":"10.1124\/jpet.105.083915_bib24","doi-asserted-by":"crossref","unstructured":"Hudson LJ, Bevan S, Wotherspoon G, Gentry C, Fox A, and Winter J (2001) VR1 protein expression increases in undamaged DRG neurons after partial nerve injury. Eur J Neurosci 13: 2105-2114.","DOI":"10.1046\/j.0953-816x.2001.01591.x"},{"key":"10.1124\/jpet.105.083915_bib25","doi-asserted-by":"crossref","unstructured":"Irie K, Hara I, Fumiko, Ozawa H, and Yajima T (2002) Calcitonin gene-related peptide CGRP-containing nerve fibers in bone tissue and their involvement in bone remodeling. Microsc Res Techni 58: 85-90.","DOI":"10.1002\/jemt.10122"},{"key":"10.1124\/jpet.105.083915_bib26","doi-asserted-by":"crossref","unstructured":"Kamei J, Zushida K, Morita K, Sasaki M, and Tanaka S (2001) Role of vanilloid VR1 receptor in thermal allodynia and hyperalgesia in diabetic mice. Eur J Pharmacol 422: 83-86.","DOI":"10.1016\/S0014-2999(01)01059-7"},{"key":"10.1124\/jpet.105.083915_bib27","doi-asserted-by":"crossref","unstructured":"Kim SH and Chung JM (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50: 355-363.","DOI":"10.1016\/0304-3959(92)90041-9"},{"key":"10.1124\/jpet.105.083915_bib28","doi-asserted-by":"crossref","unstructured":"Luo H, Cheng J, Han JS, and Wan Y (2004) Change of vanilloid receptor 1 expression in dorsal root ganglion and spinal dorsal horn during inflammatory nociception induced by complete Freund\u2019s adjuvant in rats. Neuroreport 15: 655-658.","DOI":"10.1097\/00001756-200403220-00016"},{"key":"10.1124\/jpet.105.083915_bib29","doi-asserted-by":"crossref","unstructured":"Mach DB, Rogers SD, Sabino MC, Luger NM, Schwei MJ, Pomonis JD, Keyser CP, Clohisy DR, Adams DJ, and Mantyh PW (2002) Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience 113: 155-166.","DOI":"10.1016\/S0306-4522(02)00165-3"},{"key":"10.1124\/jpet.105.083915_bib30","doi-asserted-by":"crossref","unstructured":"McCleane G (2000) The analgesic efficacy of topical capsaicin is enhanced by glyceryl trinitrate in painful osteoarthritis: a randomized, double blind, placebo controlled study. Eur J Pain 4: 355-360.","DOI":"10.1053\/eujp.2000.0200"},{"key":"10.1124\/jpet.105.083915_bib31","doi-asserted-by":"crossref","unstructured":"Michael GJ and Priestley JV (1999) Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its down-regulation by axotomy. J Neurosci 19: 1844-1854.","DOI":"10.1523\/JNEUROSCI.19-05-01844.1999"},{"key":"10.1124\/jpet.105.083915_bib32","doi-asserted-by":"crossref","unstructured":"Pogatzki EM, Gebhart GF, and Brennan TJ (2002) Characterization of Adelta- and C-fibers innervating the plantar rat hind paw one day after an incision. J Neuro-physiol 87: 721-731.","DOI":"10.1152\/jn.00208.2001"},{"key":"10.1124\/jpet.105.083915_bib33","doi-asserted-by":"crossref","unstructured":"Pomonis JD, Harrison JE, Mark L, Bristol DR, Valenzano KJ, and Walker K (2003) N-4-Tertiarybutylphenyl-4\u20133-cholorphyridin-2-yltetrahydropyrazine-12H-carboxamide BCTC, a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. In vivo characterization in rat models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 306: 387-393.","DOI":"10.1124\/jpet.102.046268"},{"key":"10.1124\/jpet.105.083915_bib34","doi-asserted-by":"crossref","unstructured":"Rashid M, Harunor, Inoue M, Bakoshi S, and Ueda H (2003a) Increased expression of vanilloid receptor 1 on myelinated primary afferent neurons contributes to the antihyperalgesic effect of capsaicin cream in diabetic neuropathic pain in mice. J Pharmacol Exp Ther 306: 709-717.","DOI":"10.1124\/jpet.103.050948"},{"key":"10.1124\/jpet.105.083915_bib35","doi-asserted-by":"crossref","unstructured":"Rashid M, Harunor, Inoue M, Kondo S, Kawashima T, Bakoshi S, and Ueda H (2003b) Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain. J Pharmacol Exp Ther 304: 940-948.","DOI":"10.1124\/jpet.102.046250"},{"key":"10.1124\/jpet.105.083915_bib36","doi-asserted-by":"crossref","unstructured":"Shin J, Cho H, Hwang SW, Jung J, Shin CY, Lee S-Y, Kim SH, Lee MG, Choi YH, Kim J, et al. (2002) Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci USA 99: 10150-10155.","DOI":"10.1073\/pnas.152002699"},{"key":"10.1124\/jpet.105.083915_bib37","doi-asserted-by":"crossref","unstructured":"Swanson DM, Dubin AE, Shah C, Nasser N, Chang L, Dax SL, Jetter M, Breiten-bucher JG, Liu C, Mazur C, et al. (2005) Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist. J Med Chem 48: 1857-1872.","DOI":"10.1021\/jm0495071"},{"key":"10.1124\/jpet.105.083915_bib38","doi-asserted-by":"crossref","unstructured":"Tohda C, Sasaki M, Konemura T, Sasamura T, Itoh M, and Kuraishi Y (2001) Axonal transport of VR1 capsaicin receptor mRNA in primary afferents and its participation in inflammation-induced increase in capsaicin sensitivity. J Neurochem 76: 1628-1635.","DOI":"10.1046\/j.1471-4159.2001.00193.x"},{"key":"10.1124\/jpet.105.083915_bib39","doi-asserted-by":"crossref","unstructured":"Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, and Julius D (1998) The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21: 531-543.","DOI":"10.1016\/S0896-6273(00)80564-4"},{"key":"10.1124\/jpet.105.083915_bib40","doi-asserted-by":"crossref","unstructured":"Tominaga M, Wada M, and Masu M (2001) Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci USA 98: 6951-6956.","DOI":"10.1073\/pnas.111025298"},{"key":"10.1124\/jpet.105.083915_bib41","doi-asserted-by":"crossref","unstructured":"Valtschanoff JG, Rustioni A, Guo A, and Hwang SJ (2001) Vanilloid receptor VR1 is both presynaptic and postsynaptic in the superficial laminae of the rat dorsal horn. J Comp Neurol 436: 225-235.","DOI":"10.1002\/cne.1063.abs"},{"key":"10.1124\/jpet.105.083915_bib42","doi-asserted-by":"crossref","unstructured":"Wahl P, Foged C, Tullin S, and Thomsen C (2001) Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist. Mol Pharmacol 59: 9-15.","DOI":"10.1124\/mol.59.1.9"},{"key":"10.1124\/jpet.105.083915_bib43","doi-asserted-by":"crossref","unstructured":"Walker KM, Urban L, Medhurst SJ, Patel S, Panesar M, Fox AJ, and McIntyre P (2003) The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 304: 56-62.","DOI":"10.1124\/jpet.102.042010"},{"key":"10.1124\/jpet.105.083915_bib44","doi-asserted-by":"crossref","unstructured":"Woo YC, Park S, Subieta AR, and Brennan TJ (2004) Changes in tissue pH and temperature after incision indicate acidosis may contribute to postoperative pain. Anesthesiology 101: 468-475.","DOI":"10.1097\/00000542-200408000-00029"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652432097X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652432097X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.105.083915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:30:14Z","timestamp":1740000614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652432097X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S002235652432097X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.105.083915","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel Transient Receptor Potential Type V1 Receptor Antagonist, Relieves Pathophysiological Pain Associated with Inflammation and Tissue Injury in Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.105.083915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}